HOME >> MEDICINE >> NEWS
Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia

BOSTON, April 30, 2004 Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride decreases and high-density lipoprotein (HDL) cholesterol increases that demonstrated statistically significant improvements from baseline.

These studies also showed that, in addition to increasing low-density lipoprotein (LDL) cholesterol particle size, ACTOS can significantly increase the size and buoyancy of HDL particles. The findings were presented today at the 13th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (AACE) in Boston.

"The data are important because they underscore the additional lipid benefits of ACTOS beyond its ability to effectively manage glucose levels and positively affect triglyceride and HDL cholesterol levels," said Mehmood Khan, M.D., F.A.C.E., senior vice president for medical and scientific affairs, Takeda Pharmaceuticals North America. "While it's well-established that increases in LDL cholesterol particle size are associated with ACTOS therapy, these new data show that HDL or 'good' cholesterol particles are similarly affected, which may further expand the lipid benefits of ACTOS."

People with diabetes are about twice as likely as those without diabetes to have high triglyceride and low HDL cholesterol levels, a condition commonly referred to as diabetic dyslipidemia. Studies have shown that the presence of large, buoyant HDL particles instead of small, dense particles may be associated with reduced cardiovascular risks.

In addition, people with diabetes tend to have a higher proportion of small, dense LDL particles, which may lead to an increase in cardiovascular risk. Smaller, more dense LDL particles are thought to more easily penetrate arterial walls to form atherosclerotic plaque.

Study Design

These studies were conducted to
'"/>


30-Apr-2004


Page: 1 2 3

Related medicine news :

1. Combination treatment helps thyroid cancer patients live longer
2. Combination therapy, not medication alone, most effective for treating children with OCD
3. Combination of erection pill and testosterone gel may benefit men who fail treatment with pill alone
4. Combination PET/CT should be used to determine stage of non-small cell lung cancer
5. Combination of toxin and poison may be novel treatment for leukemia
6. Combination drug therapy could substantially improve symptoms of rheumatoid arthritis
7. Combination therapy does not appear to benefit cardiac patients before heart catheter procedure
8. Combination drug therapy offers hope for malaria treatment
9. Combination therapy significantly delays progression of benign prostatic hyperplasia
10. Combination, order of anti-HIV drugs make a difference in first-time recipients
11. Combination of HIV/malaria increases complications during pregnancy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... (PRWEB) , ... September 07, 2018 , ... ... household and personal-care products with a presence worldwide, today announced that its Chief ... Excellence Award in Entrepreneurship. Ms. Ishaq will be presented the award on Friday, ...
(Date:9/3/2018)... ... 2018 , ... Trees with fall colors are not a good sign in ... through September. When a tree is under stress, its leaves will change color early ... Giroud Tree and Lawn provides the top five Fall warning signs for ...
(Date:9/1/2018)... ... ... SignatureCare Emergency Center is looking to award their 2018 Fall Scholarship. The $1000 ... your applications in now as the deadline is approaching fast. (July 31) , SignatureCare ... student at Texas Southern University. Wu was inspired to go into the medical field ...
(Date:8/31/2018)... RAPIDS, Mich. (PRWEB) , ... August 31, 2018 ... ... treatment provider, will host an Open House on Wednesday, September 12 from 1:00-3:00 ... options available in Grand Rapids, as well as tour the facility, meet our ...
(Date:8/31/2018)... ... ... Nitro Circus hosted the inaugural A Night to Live Like Roner event ... celebrate the life of Erik Roner, world-renowned skier, skydiver and a founding member of ... two small children, Oskar (8) and Kasper (4). A portion of the funds went ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... ... September 14, 2018 , ... ... incorporate deep sequencing to enable greater library coverage. However, severe gaps and ... potential hits remain. , Multiplexed phage display provides a simple, robust, and ...
(Date:9/13/2018)... (PRWEB) , ... September 13, 2018 , ... This September ... This annual campaign is designed to raise awareness on how to help prevent food ... 48 million people) get sick, 128,000 are hospitalized, and 3,000 die from eating contaminated ...
(Date:9/13/2018)... ... September 13, 2018 , ... ... focused on developing and commercializing gastrointestinal therapeutics, has secured acceptance of Camligo™ ... Food and Drug Administration (FDA) and European Medicines Agency (EMA), have accepted ...
Breaking Medicine Technology:
Cached News: